FDA warns of stolen batches of Novo Nordisk's Levemir insulin

06/15/2009 | United Press International · Bloomberg

Novo Nordisk and the FDA warned that nearly 130,000 vials of long-acting Levemir insulin were stolen and could have been mishandled, making them potentially dangerous for patients. The agency said it received one report of adverse events linked to the stolen lots, identified as XZF0036, XZF0037 and XZF0038.

View Full Article in:

United Press International · Bloomberg

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
CarePoint Health Plan
Jersey City, NJ
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Assistant General Counsel
Cardinal Health
Columbus, OH
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC